Follow Us

Global Healthcare Distribution Market Size, Segmentation, Trends and Growth Analysis Forecast by 2031

  •   DLR4818
  •   January, 2024
  •   Pages: 150
  •  Global

Healthcare Distribution Market Overview and Analysis:

The Global Healthcare Distribution Market was valued at USD 802.72 billion in the year 2022 and is expected to register a CAGR of 6.5% over the forecast period, 2022-2031.

Healthcare distribution refers to entire distribution practices in the healthcare sector used for enterprise resource planning, customer relationship management, medical and pharmacy supplies, wholesaling medications, along distribution and associated services.

The large economic burden of chronic diseases, technological advancement in distribution, favorable R&D investment scenario, and subsequent increase in drug launches are the main driving features of the healthcare distribution market.

Healthcare Distribution Market Latest Trends:

Artificial Intelligence, machine learning, and other technologies, the healthcare distribution market sector has witnessed an advanced change. Adopting IoT (Internet of Things) technologies has given distributors real-time information about their pharmacies and provider clients. This allows them to provide with consistent supply schedule. IoT (Internet of Things) technology also has diversions by algorithms to assess if the delivery route is not followed or if an unusual delay has occurred. With these advanced technology and safe and effective delivery tracking systems, there is increasing growth in the healthcare distribution market.

Segmentation:

The healthcare distribution market is segmented

By Product Type :

Pharmaceutical Product Distribution Services

  • Counter Drugs
  • Generic Drugs
  • Branded Drugs

Biopharmaceutical Product Distribution Services

  • Recombinant Proteins
  • Monoclonal Antibodies
  • Vaccines
  • Medical Devices Distribution Services

End-User :

  • Retail Pharmacies
  • Hospital Pharmacies
  • Other

Geography : 

  • North America
  • Europe
  • Asia-Pacific
  • Middle East
  • Africa
  • South America

The report offers the value (in USD million) for the above segments. The report offers the value (in USD million) for the above segments. The report offers the value (in USD million) for the above segments.

Healthcare Distribution Market Drivers:

Increasing Chronic Diseases:- High incidence and large economic burden of chronic diseases are the main driving features of the healthcare distribution market. For instance, according to the article published “The global burden of multiple chronic conditions: A narrative review” by the National Center for Biotechnology Information, 2021, the major driving factor for the healthcare distribution market is the high incidence of chronic disease cases like diabetes, chronic obstructive pulmonary and cancer, etc. are associated with a higher level of health resource utilization patterns.

Similarly, according to the Canadian Medical Association Journal, 2021, the number of patients with chronic disease increased by 11.0% over the 10-year study period to 9.8 million in 2017/18, and the number with multimorbidity increased by 12.2% to 6.5 million. Thus, the number of people suffering from chronic disease is constantly increasing. To cure these disorders, cellular treatment, biomarker imaging, generics, biosimilars, and other wide range of healthcare medications are used. These created necessities for effective healthcare distribution services. Generics are also in high demand due to their cost-effectiveness. Furthermore, Thus, increasing cases of chronic disease are driving the healthcare distribution market.

There is a growing need for medical device equipment such as vitro diagnostic equipment, diagnostic imaging equipment, and endoscopic equipment are used in this healthcare industry for a variety of functions.  Therefore, the healthcare distribution market which ensures a safe and effective delivery network to fulfill the need of consumers is required and thus directly drives the healthcare distribution market.

Healthcare Distribution Market Technological Advancements

Technological advancements in distribution are boosting the healthcare distribution market. For instance, ScienceOpen.com in 2021, titled, Applications of Artificial Intelligence (AI) Healthcare: A Review summarizes that with the coming of technologies such as Artificial Intelligence, machine learning, and other technologies, the healthcare distribution market sector has witnessed an advanced change. Adopting IoT (Internet of Things) technologies has given distributors real-time information about their pharmacies and provider clients. This allows them to provide with consistent supply schedule. IoT (Internet of Things) technology also has diversions by algorithms to assess if the delivery route is not followed or if an unusual delay has occurred. Due to this advanced technology and safe and effective delivery tracking system, there is increasing growth in the healthcare distribution market. *

Restraints High Cost of Healthcare Distribution

The healthcare distribution is mainly dependent on AI and IoT since these technologies are quite expensive as result slowing down the studied market growth

COVID-19 Impact on the Healthcare Distribution Market

The COVID-19 pandemic was an incomparable global public health emergency, it has impacted almost every sector of the industry including the healthcare distribution market industry. The strict lockdowns and government regulations intended to slow down the spread of COVID-19, restricting the movement of people and so the sales of the healthcare distribution market were affected during the initial phase of the lockdown.

For instance, an article published in Maritime Economics and Logistics, in 2021 summarizes that COVID-19 impacted manufacturing activity and caused disruptions in transportation and logistics activities globally, these factors lead to a sudden and drastic fall in the economy. Within a few weeks of the COVID-19 crisis a considerable change in consumer behaviour and demand, consumer purchase patterns, re-routing of the supply chain, and significant government intervention was observed. The supply chain disruptions during the initial phase of the lockdown were a major downfall for the distribution market resulting in a slowdown in the healthcare distribution activities and this led to the setting up of a strong supply chain network for efficient healthcare distribution services.

The disease will inevitably be an overwhelming burden on healthcare systems that cannot be effectively dealt with by existing facilities or responses based on conventional approaches. All these long-term effects of COVID-19 have resulted in significant healthcare industrial growth and have driven the healthcare distribution market.

Segmentation Trends

Retail Pharmacy is Expected to Witness Growth Over the Forecast Period

A retail pharmacy is defined as any pharmacy where drugs are compounded, dispensed, stored, or sold or where prescriptions are filled or dispensed to the general public. The Retail pharmacy witnessed the expected growth over the forecast period and accounts for the significant growth in the market. For instance, the Journal of Economics, 2022, states that retail pharmacies deal with many details of the prescription. In developed countries, some affordable healthcare schemes and programs led to a significant increase in the number of prescriptions. The government is also putting forward significant measures to reduce healthcare spending which has increased the number of prescriptions reaching retail pharmacies which is like fuel to this segment’s revenue growth over the forecast period. The affordable generic drug demands account for the increase in demand for retail pharmacies.

For instance, the article titled “Using Commercial Retail Pharmacy Data To Develop a Teaching Strategy for Population Health Pharmacy” states that the retail pharmacy has several benefits which include scaling up the economy, technology development, customers having better access, lowering the unit cost, etc. because of all these reasons retail pharmacies have gained significant growth in recent years. According to the journal, International Journal of Health Services in 2021, the social media analytic framework is significantly improving operation and service management which has driven the growth in retail pharmacy sales.  

For instance, in the International Journal of Healthcare Management in 2021, the governments in different countries have removed regulations to offer easy broader access to pharmacy services.  Such regulation has spurred the competition by allowing the entry of new drug distribution channels, effectively increasing the demand for retail pharmacies.

Geography Trends North America is Expected to Dominate the Healthcare Distribution Market 

North America is expected to dominate the market owing to factors such as recent advancements. For instance, an article published in the journal, Information Systems Frontiers in 2021, titled “The Application of the Principles of Responsible AI on Social Media Marketing for Digital Health” states that technologies dominate this market. Due to a significant increase in the number of prescriptions filled at retail pharmacies, and effective supply chain management, distributors have turned to modern industrial technology such as machine learning and Artificial Intelligence for big data and standardized influence, Due to this the healthcare distribution market is effectively growing in the United States. Using AI technologies in healthcare, coupled with patients’ growing adoption of AI-enabled devices, allows the collection and storage of and access to large-scale data, both by healthcare providers and technology vendors.

Further, advanced healthcare infrastructure and increasing investments by biotechnology companies in research activities are expected to drive market growth in the region. For instance, the American Journal of Public Health 2021, states how healthcare centers’ infrastructure supports the healthcare distribution market in the United States. It also tells that along with infrastructure skilled manpower can also be an initiative to increase the efficiency of the healthcare distribution market. Also due to the coming of E-pharmacy, the sales and distribution of pharmaceutical and medical products online mode have increased. This has also led to an increase in sales of retail pharmacies in North America.

Therefore, owing to the aforementioned factors the growth of the studied market is anticipated in the North American region.

Healthcare Distribution Market Competitive Landscape

The healthcare distribution market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known as

Key Players :

  • McKesson Corporation
  • Cardinal Health
  • Morris and Dickson Company
  • Smith Drug Company
  • Owens and Minor Inc.
  • Patterson Companies
  • PHOENIX Group,
  • Owens Medline Industries
  • Other  

Recent Developments

  • In 2022, Microsoft acquired Nuance, a provider of conversational AI and cloud-based ambient clinical intelligence for healthcare providers. Nuance’s products include the Dragon Ambient experience, Dragon Medical One, and PowerScribe for radiology reporting. Its solutions, which work with core healthcare systems, including relationships with Electronic Health Records, are currently used by more than 55% of physicians and 75% of radiologists in the U.S. and used in 77% of U.S. hospitals.
  • In March 2021, Cardinal Health and FourKites established a global corporation to improve the tracking of medical equipment, pharmaceutical items, first aid supplies, and personal protective equipment in transit to hospitals, pharmacies, and other care facilities throughout the world.


Frequently Asked Questions (FAQ) :

Q1. How big is the Healthcare Distribution Market?

The Global Healthcare Distribution Market was valued at USD 802.72 billion in the year 2022 and is expected to register a CAGR of 6.5% over the forecast period, 2022-2031.

Q2. What segments are covered in the Healthcare Distribution Market Report?

Healthcare Distribution Market Report covers segments like - By Product Type, End User and Geography.

Q3. What are the Drivers of the Healthcare Distribution Market ?

High incidence and large economic burden of chronic diseases are the main driving features of the healthcare distribution market.

Q4. Which Region is expected to hold the highest Market share ?

North America is expected to dominate the market owing to factors such as recent advancements
INTRODUCTION            
    Study Assumptions and Market Definition        
    Scope of the Study        
RESEARCH METHODOLOGY            
EXECUTIVE SUMMARY            
MARKET DYNAMICS            
    Market Overview        
    Market Drivers        
        High Incidence and Large Economic Burden of Chronic Diseases    
        Favorable R&D Investment Scenario, and Subsequent Increase in Drug Launches    
    Market Restraints        
        High Cost of Healthcare Distribution    
    Porter's Five Force Analysis        
        Threat of New Entrants    
        Bargaining Power of Buyers/Consumers    
        Bargaining Power of Suppliers    
        Threat of Substitute Products    
        Intensity of Competitive Rivalry    
MARKET SEGMENTATION (Market Size by Value - USD million)            
    By Product Type        
        Pharmaceutical Product Distribution Services    
        Biopharmaceutical Product Distribution Service    
        Medical Devices Distribution Services    
    By Application        
        Antibiotics    
        Recombinant Proteins    
        Probiotics    
        Others    
    By End-users        
        Retail Pharmacies    
         Hospital Pharmacies    
        Others    
    Geography        
        North America    
            United States
            Canada
            Mexico
        Europe    
            Germany
            United Kingdom
            France
            Italy
            Spain
            Rest of Europe
        Asia-Pacific    
            China
            Japan
            India
            Australia
            South Korea
            Rest of Asia-Pacific
        Middle East and Africa    
            GCC
            South Africa
            Rest of Middle East and Africa
        South America    
            Brazil
            Argentina
            Rest of South America
COMPETITIVE LANDSCAPE            
    Company Profiles        
         McKesson Corporation    
        Cardinal Health    
        Morris and Dickson Company    
        Smith Drug Company    
        Owens and Minor Inc    
        Patterson Companies    
        PHOENIX Group    
        Shanghai Pharmaceutical Group    
        Medline Industries    
        CuraScript SD    
MARKET OPPORTUNITIES AND FUTURE TRENDS            

Request for List of Figure


Research Process

Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.

In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization

FIGURE 1: DLR RESEARH PROCESS

research-methodology1

Primary Research

Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.

In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.

It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.

Secondary Research

Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.

Market Size Estimation

Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.

Forecast Model

research-methodology2